Annual Report · 10-K
Co-Diagnostics, Inc.
CODXNASDAQEQUITYCurrent
Annual Report
Company context
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to regulatory review and not currently for sale) and to identify genetic markers for use in applications other than infectious disease.
Current securities
Document unavailable
This filing is not currently available in the archive. Read it on SEC EDGAR ↗